SCHEMBL22737101

SCHEMBL22737101

N#Cc1cccc(C#N)c1-c1ccc2c(c1)c1ccccc1n2-c1cccc(-c2cccc(-n3c4ccccc4c4ccccc43)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
IMPDH2 P12268 1/20 0.35
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
MAOA P21397 2/20 0.34
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
TSPO P30536 1/20 0.33
GRIA1 P42261 1/20 0.33
CACNG8 Q8WXS5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22737186 0.97 ATM (0.42) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737097 0.94 KDM4E (0.43) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737296 0.94 KDM4E (0.43) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737927 0.93 KDM4E (0.40) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737758 0.93 ALDH1A1 (0.40) ATMSMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22737099 0.93 ALDH1A1 (0.40) ATMSMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL23503063 0.92 ATM (0.42) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737403 0.92 L3MBTL1 (0.51) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL23502959 0.91 ATM (0.41) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737047 0.91 ATM (0.41) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE CCNE2, CRY2, PER2 KDM4E 3559/4885ATM 1504/4885L3MBTL1 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.